1 Result(s)

Article

NFL is a marker of treatment response in children with SMA treated with nusinersen

Recently, the anti-sense oligonucleotide drug nusinersen was approved for spinal muscular atrophy (SMA) and our aim was to find a response marker for this treatment.

Bob Olsson, Lars Alberg, Nicholas C. Cullen, Eva Michael… in Journal of Neurology (2019)